SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-18-000051
Filing Date
2018-06-12
Accepted
2018-06-12 08:01:43
Documents
3
Period of Report
2018-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K opiant_8-kricharddalyappoi.htm 8-K 32730
2 EXHIBIT 10.1 director_agreementxrichard.htm EX-10.1 28318
3 EXHIBIT 99.1 opiant_prxricharddalyjoins.htm EX-99.1 12453
  Complete submission text file 0001385508-18-000051.txt   74899
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 18893570
SIC: 1000 Metal Mining